4-(9-oxoxanthen-2-yl)oxybenzoic acid

ID: ALA4749993

Chembl Id: CHEMBL4749993

PubChem CID: 162650998

Max Phase: Preclinical

Molecular Formula: C20H12O5

Molecular Weight: 332.31

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  O=C(O)c1ccc(Oc2ccc3oc4ccccc4c(=O)c3c2)cc1

Standard InChI:  InChI=1S/C20H12O5/c21-19-15-3-1-2-4-17(15)25-18-10-9-14(11-16(18)19)24-13-7-5-12(6-8-13)20(22)23/h1-11H,(H,22,23)

Standard InChI Key:  JDWZOPQQHHBSHB-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA4749993

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 332.31

Molecular Weight (Monoisotopic): 332.0685

AlogP: 4.44

#Rotatable Bonds: 3

Polar Surface Area: 76.74

Molecular Species: ACID

HBA: 4

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 4.30

CX Basic pKa: ┄

CX LogP: 4.12

CX LogD: 1.15

Aromatic Rings: 4

Heavy Atoms: 25

QED Weighted: 0.56

Np Likeness Score: -0.02

References

1. Hayashi K,Kondo N,Omori N,Yoshimoto R,Hato M,Shigaki S,Nagasawa A,Ito M,Okuno T.  (2021)  Discovery of a benzimidazole series as the first highly potent and selective ACSL1 inhibitors.,  33  [PMID:33285268] [10.1016/j.bmcl.2020.127722]

Source

Source(1):

• Scientific Literature